667 related articles for article (PubMed ID: 35468826)
21. Analysis of endoplasmic reticulum stress-related gene signature for the prognosis and pattern in diffuse large B cell lymphoma.
Zhang C; Lin Q; Li C; Chen Z; Deng M; Weng H; Zhu X
Sci Rep; 2023 Aug; 13(1):13894. PubMed ID: 37626099
[TBL] [Abstract][Full Text] [Related]
22. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
23. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
24. An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers.
Liu Y; Sheng L; Hua H; Zhou J; Zhao Y; Wang B
Technol Cancer Res Treat; 2023; 22():15330338231180785. PubMed ID: 37551117
[No Abstract] [Full Text] [Related]
25. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
[TBL] [Abstract][Full Text] [Related]
26. Identifying
Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
PeerJ; 2023; 11():e16618. PubMed ID: 38099311
[TBL] [Abstract][Full Text] [Related]
27. A prognostic immune risk score for diffuse large B-cell lymphoma.
Ma SY; Tian XP; Cai J; Su N; Fang Y; Zhang YC; Wang JN; Peter Gale R; Cai QQ
Br J Haematol; 2021 Jul; 194(1):111-119. PubMed ID: 33942291
[TBL] [Abstract][Full Text] [Related]
28. Identification of Aging-Related Genes Associated with Prognostic Value and Immune Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma.
Luo C; Nie H; Yu L
Oxid Med Cell Longev; 2022; 2022():3334522. PubMed ID: 35069971
[TBL] [Abstract][Full Text] [Related]
29. The Dark Side of Pyroptosis of Diffuse Large B-Cell Lymphoma in B-Cell Non-Hodgkin Lymphoma: Mediating the Specific Inflammatory Microenvironment.
Wang W; Xu SW; Teng Y; Zhu M; Guo QY; Wang YW; Mao XL; Li SW; Luo WD
Front Cell Dev Biol; 2021; 9():779123. PubMed ID: 34805183
[No Abstract] [Full Text] [Related]
30. Ferroptosis Markers Predict the Survival, Immune Infiltration, and Ibrutinib Resistance of Diffuse Large B cell Lymphoma.
Weng J; Chen L; Liu H; Yang XP; Huang L
Inflammation; 2022 Jun; 45(3):1146-1161. PubMed ID: 35064379
[TBL] [Abstract][Full Text] [Related]
31. Identification and Development of a 4-Gene Ferroptosis Signature Predicting Overall Survival for Diffuse Large B-Cell Lymphoma.
Wu H; Zhang J; Fu L; Wu R; Gu Z; Yin C; He K
Technol Cancer Res Treat; 2023; 22():15330338221147772. PubMed ID: 36762399
[No Abstract] [Full Text] [Related]
32. Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients.
Zhao C; Huang R; Zeng Z; Yang S; Lu W; Liu J; Wei Y; Guo H; Zhang Y; Yan P; Huang Z; Shi J
Aging (Albany NY); 2021 May; 13(10):14131-14158. PubMed ID: 34001679
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma.
Zhang B; Zhang T; Zheng Z; Lin Z; Wang Q; Zheng D; Chen Z; Ma Y
Front Oncol; 2022; 12():1020566. PubMed ID: 36713586
[TBL] [Abstract][Full Text] [Related]
34. Identification and verification of microtubule associated genes in lung adenocarcinoma.
Wei Y; Yang C; Wei J; Li W; Qin Y; Liu G
Sci Rep; 2023 Sep; 13(1):16134. PubMed ID: 37752167
[TBL] [Abstract][Full Text] [Related]
35. Identification and Validation of a Prognostic Gene Signature for Diffuse Large B-Cell Lymphoma Based on Tumor Microenvironment-Related Genes.
Pan T; He Y; Chen H; Pei J; Li Y; Zeng R; Xia J; Zuo Y; Qin L; Chen S; Xiao L; Zhou H
Front Oncol; 2021; 11():614211. PubMed ID: 33692952
[TBL] [Abstract][Full Text] [Related]
36. Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration.
Chen X; Hu S; Han Y; Cai Y; Lu T; Hu X; Chu Y; Zhou X; Wang X
Clin Exp Med; 2023 Oct; 23(6):2601-2617. PubMed ID: 36682001
[TBL] [Abstract][Full Text] [Related]
37. A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma.
Guan M; Zhao H; Zhang Q; Li L; Wang X; Tang B
Expert Rev Mol Diagn; 2024 May; 24(5):439-457. PubMed ID: 38709202
[TBL] [Abstract][Full Text] [Related]
38. Unraveling the unfolded protein response signature: implications for tumor immune microenvironment heterogeneity and clinical prognosis in stomach cancer.
Ouyang W; Liu Y; Huang H; Tan Y; Huang Z; Jia X; Yu Y; Yao H
Aging (Albany NY); 2024 May; 16(9):7818-7844. PubMed ID: 38700505
[TBL] [Abstract][Full Text] [Related]
39. Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature.
Shen L; Huang H; Li J; Chen W; Yao Y; Hu J; Zhou J; Huang F; Ni C
Front Immunol; 2023; 14():1199465. PubMed ID: 37469520
[TBL] [Abstract][Full Text] [Related]
40. A glycolysis-related gene signatures in diffuse large B-Cell lymphoma predicts prognosis and tumor immune microenvironment.
Cui Y; Leng C
Front Cell Dev Biol; 2023; 11():1070777. PubMed ID: 36755971
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
